The evaluation of drug interactions in preclinical stages optimizes novel drug development
Specialized manufacturer of in vitro kits indicated to evaluate pharmacological relevant efflux and uptake receptors for TDI assays.
Role of pharmacological efflux receptors in cancer treatment resistance
Transmembrane efflux receptors, Pgp, MRP1 and BCRP has shown a relevant effect in the chemoterapy resistance.
Recommended cell-based in vitro testing to assess BCRP protein-mediated transport
PreadyPort BCRP is a in vitro system based on transfected MDCKII cells overexpressing the BCRP transporter.
MDCK II cells overexpressing MDR1 protein. A must assay for drug development.
ReadyCell provides ready-to-use in vitro system for assessing the pharmacological role of the P-gp receptor in preclinical stages.
Discover how in vitro Caco-2 cells help you evaluate novel therapeutic molecules
Caco-2 cells are considered a reference cellular model for basic research and drug discovery projects. ReadyCell supplies systems worldwide.
PreadyTake MATE1, Screening Renal and Hepatic Drug Metabolism
In vitro systems based on HEK293 cells are a recommended technique to assess MATE1 transporter interactions during preclinical stages.
